应用精细化防控措施降低中心静脉导管相关血流感染发病率
作者:
作者单位:

1.华中科技大学同济医学院附属同济医院医院感染管理科, 湖北 武汉 430030;2.华中科技大学同济医学院附属同济医院肝脏外科, 湖北 武汉 430030

作者简介:

通讯作者:

王伟  E-mail: freeskywang@163.com

中图分类号:

+2]]>

基金项目:

国家自然科学基金项目(71974062)


Application of precise prevention and control measures in reducing incidence of central venous catheter-related bloodstream infection
Author:
Affiliation:

1.Department of Healthcare-associated Infection Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;2.Department of Liver Surgery, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    目的 探讨应用精细化防控措施降低中心静脉导管相关血流感染(CRBSI)的效果。 方法 选取某三级甲等医院2019年1月—2020年12月中心静脉置管≥48 h的患者。2019年1—12月为干预前期,2019年12月底全院开始实施精细化防控措施,2020年1—12月为干预后期。比较干预前后医务人员CRBSI防控措施执行率和患者CRBSI发病率。 结果 2020年医务人员CRBSI防控措施执行率为99.06%(191 504/193 324),高于2019年的87.90%(382 550/435 194),差异有统计学意义(χ2=21 046.64,P<0.001)。2019、2020年分别发生CRBSI 54、11例,两组感染患者性别、年龄、白细胞计数、降钙素原和C反应蛋白水平比较,差异均无统计学意义(均P>0.05)。2019年患者置管总日数为350 473 d,CRBSI发病率为0.15‰;2020年置管总日数为186 856 d,CRBSI发病率为0.06‰,两组患者CRBSI发病率比较差异有统计学意义(χ2=5.912,P=0.015)。 结论 实施精细化防控措施可降低中心静脉置管患者CRBSI发病率。

    Abstract:

    Objective To explore the application effect of precise prevention and control measures on reducing central venous catheter-related bloodstream infection (CRBSI). Methods Patients with central venous catheterization ≥48 hours in a tertiary first-class hospital from January 2019 to December 2020 were selected. January to December 2019 was pre-intervention period, the whole hospital began to implement precise prevention and control measures at the end of December 2019, and January to December 2020 was post-intervention period. Implementation rate of CRBSI prevention and control measures of health care workers and incidence of CRBSI among patients before and after intervention was compared. Results The implementation rate of CRBSI prevention and control measures in 2020 was 99.06%(191 504/193 324), which was higher than 87.90%(382 550/435 194)in 2019, difference was significant (χ2=21 046.64, P < 0.001). There were 54 and 11 cases of CRBSI in 2019 and 2020 respectively, there were no significant differences in gender, age, leukocyte count, procalcitonin and C-reactive protein between two groups of patients (all P>0.05). The total catheterization days in 2019 was 350 473 days, incidence of CRBSI was 0.15‰; the total catheterization days in 2020 was 186 856 days, incidence of CRBSI was 0.06‰, difference in incidence of CRBSI between two groups of patients was significant(χ2=5.912, P=0.015). Conclusion Implementation of precise prevention and control measures can reduce the incidence of central venous CRBSI in patients undergoing central venous catheterization.

    参考文献
    相似文献
引用本文

吕倩,赖晓全,魏诗晴,等.应用精细化防控措施降低中心静脉导管相关血流感染发病率[J]. 中国感染控制杂志,2022,(4):363-367. DOI:10.12138/j. issn.1671-9638.20222145.
Qian LYU, Xiao-quan LAI, Shi-qing WEI, et al. Application of precise prevention and control measures in reducing incidence of central venous catheter-related bloodstream infection[J]. Chin J Infect Control, 2022,(4):363-367. DOI:10.12138/j. issn.1671-9638.20222145.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-11-18
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-04-28
  • 出版日期: